[Federal Register Volume 67, Number 144 (Friday, July 26, 2002)]
[Notices]
[Pages 48958-48959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-18928]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration on the Boston Stock Exchange, Inc. (Implant Sciences 
Corporation, Common Stock, $.10 par value, and Warrants, no par value ) 
File No. 1-15087

July 19, 2002.
    Implant Sciences Corporation, a Massachusetts corporation 
(``Issuer''), has filed an application with the Securities and Exchange 
Commission (``Commission''), pursuant to section 12(d) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its Common Stock, $.10 par value, and 
Warrants, no par value (``Securities''), from listing and registration 
on the Boston Stock Exchange, Inc. (``BSE'' or ``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Issuer stated in its application that it has complied with the 
Rules of the BSE that govern the removal of securities from listing and 
registration on the Exchange. In making the decision to withdraw the 
Securities from listing and registration on the BSE, the Issuer 
considered the relative liquidity provided by the BSE versus other 
securities exchanges and the direct and indirect cost associated with 
maintaining multiple listings. The Issuer stated in its application 
that the Securities have been trading on the

[[Page 48959]]

American Stock Exchange LLC (``Amex'') since May 8, 1999. The Issuer 
represented that it will maintain its listing on the Amex.
    The Issuer's application relates solely to the Securities' 
withdrawal from listing on the BSE and shall not affect its listing on 
the Amex or its obligation to be registered under section 12(b) of the 
Act \3\.
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
---------------------------------------------------------------------------

    Any interested person may, on or before August 12, 2002, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW, Washington, DC 20549-0609, facts bearing upon whether 
the application has been made in accordance with the rules of the BSE 
and what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\4\
---------------------------------------------------------------------------

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 02-18928 Filed 7-25-02; 8:45 am]
BILLING CODE 8010-01-P